Performance of Xpert MTB/RIF and XDR Assay for Diagnosis of Pulmonary Tuberculosis and Resistant Pulmonary TB
NCT06392594 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 46
Last updated 2024-04-30
Summary
To determine how accurate Xpert MTB/RIF and XDR for diagnosis of pulmonary TB and Rifampicin resistance
Conditions
- Tuberculosis, Pulmonary
Interventions
- GENETIC
-
xpert MTB , XDR assay
To determine how accurate Xpert MTB/RIF and XDR for diagnosis of pulmonary TB and Rifampicin resistance
Sponsors & Collaborators
-
Assiut University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-04-23
- Primary Completion
- 2025-04-23
- Completion
- 2025-05-23
More Related Trials
-
Trial of Point-of-treatment Xpert MTB/RIF Assay
NCT01554384 ·Status: COMPLETED ·Phase: NA
-
Xpert MTB/RIF Test in the Diagnosis of Pulmonary Tuberculosis
NCT04433195 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of Non-Inferiority of Two Fast Follower Nucleic Acid Amplification Tests
NCT02252198 ·Status: COMPLETED
-
Development of a Rapid and Accurate Diagnostic Assay for Tuberculosis
NCT03423550 ·Status: UNKNOWN
-
Xpert MTB/RIF Ultra Trial
NCT07135622 ·Status: COMPLETED ·Phase: NA
-
DIAgnostics for Multidrug Resistant Tuberculosis in Africa
NCT03303963 ·Status: COMPLETED
-
Improving TB Diagnosis and Treatment Through Basic, Applied and Health Systems Research
NCT03356925 ·Status: COMPLETED ·Phase: NA
-
Study of GeneXpert Mycobacterium Tuberculosis/ Rifampicin (MTB/RIF) Versus the Routine Methods for Detection of Mycobacterium Tuberculosis
NCT06409572 ·Status: NOT_YET_RECRUITING
-
Evaluation of Different Diagnostic Methods of Tuberculosis in Assiut University Hospitals
NCT06666972 ·Status: NOT_YET_RECRUITING
-
Xpert MTB/XDR Clinical Evaluation Trial
NCT03728725 ·Status: COMPLETED
-
Development of Automated Molecular Diagnostic Platform for Tuberculosis Diagnosis (New Assay TB)
NCT04988984 ·Status: UNKNOWN
-
Evaluating Accuracy, Impact, and Operational Challenges of GeneXpert Use for TB Case Finding Among HIV-infected Persons
NCT02538952 ·Status: COMPLETED ·Phase: PHASE4
-
Improve Treatment Outcomes for Tuberculosis Infection in Tertiary Care Hospitals
NCT03042754 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Development of Molecular Diagnostic Platform for Tuberculosis
NCT04734236 ·Status: UNKNOWN ·Phase: NA
-
Effect of Xpert MTB/RIF on Patient Outcomes
NCT02729532 ·Status: COMPLETED
-
Feasibility and Accuracy of a Novel Xpert Cartridge
NCT02251327 ·Status: COMPLETED
-
Establishing a Diagnostic Test for Non-tuberculous Mycobacteria Lung Infection Using Non-tuberculous Mycobacteria Antigen Stimulation Test: From Immune Base, Standardized Setup to Validation
NCT01676142 ·Status: UNKNOWN
-
Assessing the Ability of the T-SPOT®.TB Test
NCT03929705 ·Status: COMPLETED
-
Safety, Tolerability, Extended Early Bactericidal Activity and PK of Higher Doses Rifampicin in Adults With Pulmonary TB
NCT01392911 ·Status: COMPLETED ·Phase: PHASE2
-
Quantitative Measurement of Plasma and Urine MTB Cell-free DNA Level
NCT07170735 ·Status: RECRUITING
-
Whole Blood Bactericidal Activity (WBA) Against Mycobacterium Tuberculosis of Rifampicin in Healthy Volunteers
NCT02387242 ·Status: SUSPENDED ·Phase: PHASE1
-
Clinical Evaluation of the Truenat Point-of-care Tuberculosis Diagnostic Test
NCT03712709 ·Status: COMPLETED
-
The Role of a Mycobacterium Growth Inhibition Assay to Quantify Host Immune Control of M. Tuberculosis
NCT06580639 ·Status: RECRUITING
-
Impact of Systematic Early Tuberculosis Detection Using Xpert MTB/RIF Ultra in Children With Severe Pneumonia in High Tuberculosis Burden Countries (TB-Speed Pneumonia)
NCT03831906 ·Status: COMPLETED ·Phase: NA
-
Role of Genexpert in Extra Pulmonary Tuberculosis
NCT03173261 ·Status: UNKNOWN ·Phase: NA